Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrian S Ray

Showing results (51-60 of 103) with videos related to

Pageof 11
Sort By:
Antimicrobial Agents and Chemotherapy|July 11, 2012
Compared to subcutaneous tenofovir, oral tenofovir disoproxyl fumarate administration preferentially concentrates the drug into gut-associated lymphoid cells in simian immunodeficiency virus-infected macaquesKoen K A Van Rompay, Darius Babusis, Zachary Abbott, et al.
Antimicrobial Agents and Chemotherapy|September 29, 2006
Mechanism of active renal tubular efflux of tenofovirAdrian S Ray, Tomas Cihlar, Kelly L Robinson, et al.
Nucleosides, Nucleotides & Nucleic Acids|September 24, 2015
Synthesis of 1'-C-cyano pyrimidine nucleosides and characterization as HCV polymerase inhibitorsThorsten A Kirschberg, Michael Mish, Neil H Squires, et al.
Journal of Clinical Pharmacology|December 31, 2013
Pharmacokinetics of cobicistat boosted-elvitegravir administered in combination with rosuvastatinJoseph M Custodio, Hui Wang, Jia Hao, et al.
AIDS (London, England)|October 18, 2005
A combination of decreased NRTI incorporation and decreased excision determines the resistance profile of HIV-1 K65R RTKirsten L White, Nicolas A Margot, John K Ly, et al.
Drug Metabolism and Pharmacokinetics|April 30, 2020
Species differences in liver accumulation and metabolism of nucleotide prodrug sofosbuvirTing Wang, Darius Babusis, Yeojin Park, et al.
Antimicrobial Agents and Chemotherapy|December 7, 2007
Intracellular metabolism of the nucleotide prodrug GS-9131, a potent anti-human immunodeficiency virus agentAdrian S Ray, Jennifer E Vela, Constantine G Boojamra, et al.
Bioorganic & Medicinal Chemistry Letters|May 4, 2013
Evaluation of 2'-α-fluorine modified nucleoside phosphonates as potential inhibitors of HCV polymeraseJay P Parrish, Sharon K Lee, Constantine G Boojamra, et al.
Bioorganic & Medicinal Chemistry Letters|June 8, 2014
Preparation and biological evaluation of 1'-cyano-2'-C-methyl pyrimidine nucleosides as HCV NS5B polymerase inhibitorsMichael R Mish, Aesop Cho, Thorsten Kirschberg, et al.
Pharmacogenetics and Genomics|December 9, 2014
A pharmacogenetic candidate gene study of tenofovir-associated Fanconi syndromeAmber Dahlin, Matthias Wittwer, Melanie de la Cruz, et al.
Pageof 11

Showing results (51-60 of 103) with videos related to

Sort By:
Pageof 11
Antimicrobial Agents and Chemotherapy|July 11, 2012
Compared to subcutaneous tenofovir, oral tenofovir disoproxyl fumarate administration preferentially concentrates the drug into gut-associated lymphoid cells in simian immunodeficiency virus-infected macaquesKoen K A Van Rompay, Darius Babusis, Zachary Abbott, et al.
Antimicrobial Agents and Chemotherapy|September 29, 2006
Mechanism of active renal tubular efflux of tenofovirAdrian S Ray, Tomas Cihlar, Kelly L Robinson, et al.
Nucleosides, Nucleotides & Nucleic Acids|September 24, 2015
Synthesis of 1'-C-cyano pyrimidine nucleosides and characterization as HCV polymerase inhibitorsThorsten A Kirschberg, Michael Mish, Neil H Squires, et al.
Journal of Clinical Pharmacology|December 31, 2013
Pharmacokinetics of cobicistat boosted-elvitegravir administered in combination with rosuvastatinJoseph M Custodio, Hui Wang, Jia Hao, et al.
AIDS (London, England)|October 18, 2005
A combination of decreased NRTI incorporation and decreased excision determines the resistance profile of HIV-1 K65R RTKirsten L White, Nicolas A Margot, John K Ly, et al.
Drug Metabolism and Pharmacokinetics|April 30, 2020
Species differences in liver accumulation and metabolism of nucleotide prodrug sofosbuvirTing Wang, Darius Babusis, Yeojin Park, et al.
Antimicrobial Agents and Chemotherapy|December 7, 2007
Intracellular metabolism of the nucleotide prodrug GS-9131, a potent anti-human immunodeficiency virus agentAdrian S Ray, Jennifer E Vela, Constantine G Boojamra, et al.
Bioorganic & Medicinal Chemistry Letters|May 4, 2013
Evaluation of 2'-α-fluorine modified nucleoside phosphonates as potential inhibitors of HCV polymeraseJay P Parrish, Sharon K Lee, Constantine G Boojamra, et al.
Bioorganic & Medicinal Chemistry Letters|June 8, 2014
Preparation and biological evaluation of 1'-cyano-2'-C-methyl pyrimidine nucleosides as HCV NS5B polymerase inhibitorsMichael R Mish, Aesop Cho, Thorsten Kirschberg, et al.
Pharmacogenetics and Genomics|December 9, 2014
A pharmacogenetic candidate gene study of tenofovir-associated Fanconi syndromeAmber Dahlin, Matthias Wittwer, Melanie de la Cruz, et al.
Pageof 11